The role of topotecan in cancer ginecology treatment
The high morbidity, often latent, asymptomatic disease development is not optimal therapy in the first line, causes the development of the frequent recurrence of tumors, requiring second and thirds lines of chemotherapy. The use of topotecan in standard mode is limited by myelosuppression, therefore...
| Autors principals: | , , |
|---|---|
| Format: | Article |
| Idioma: | Russian |
| Publicat: |
ABV-press
2017-02-01
|
| Col·lecció: | Опухоли женской репродуктивной системы |
| Matèries: | |
| Accés en línia: | https://ojrs.abvpress.ru/ojrs/article/view/525 |